Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Therapies and procedures
Learn more about therapy options to treat heart failure patients.
Our unique cardiac resynchronization therapy (CRT) portfolio of devices provides personalized patient care. Medtronic CRT-D and CRT-P devices include a variety of comprehensive features, exclusive algorithms, and implant solutions designed to treat your heart failure patients.
Medtronic is focused on innovative options to help your heart failure patients feel better with our advanced therapies and monitoring solutions.1-9
Providing unique features like the AdaptivCRT™ algorithm10 and TriageHF™ technology,11 Medtronic CRT-D and CRT-P devices include a variety of comprehensive features to help tailor heart failure therapy for each of your patients' needs.
Our advanced therapies, monitoring solutions, and management services are designed to help you help your heart failure patients feel better, while improving the efficiency and effectiveness of heart failure care.1-9
Reducing procedure-related complications is now more important than ever. Learn about the TYRX™ Absorbable Antibacterial Envelope, an innovative solution aimed to improve procedure-related outcomes.12
Stay up to date on product updates and events.
Gold MR, et al. Reduced 30-Day Hospital Readmissions in Systolic Heart Failure Patients with Cardiac Resynchronization Therapy: Evidence from 5 Randomized Controlled Trials. Presented November 16, 2014 at AHA 2014 (Poster session).
Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. April 14, 2005;352(15):1539-1549.
Cleland JG, Daubert JC, Erdmann E, et al. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J. August 2006;27(16):1928-1932.
Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. May 20, 2004;350(21):2140-2150.
Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med. June 13, 2002;346(24):1845-1853.
Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. May 28, 2003;289(20):2685-2694.
Linde C, Abraham WT, Gold MR, et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll. Cardiol. December 2, 2008;52(23):1834-1843.
Tang AS, Wells GA, Talajic M, et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med. December 16, 2010;363(25):2385-2395.
Moss AJ, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. October 1, 2009;361(14):1329-1338.
Singh JP, et al. Improved Survival With Dynamic Optimization Of CRT Pacing Using AdaptivCRT Algorithm: Analysis Of Real-world Patient Data. Presented at HRS 2018 (AB37-06).
Medtronic CareLink Model 5242 TriageHF feature in the Heart Failure Management Report Technical Manual M995788A001 B.
Tarakji KG, Mittal S, Kennergren C, et al. Antibacterial Envelope to Prevent Cardiac Implantable Device Infection. N Engl J Med. May 16, 2019;380(20):1895-1905.